ARCHIVES

New Drug Reverses Damage To Liver In Stem Cell Transplant

This article is from The Cancer Letter archive.

Vol. 25 No. 9 | September 27, 2002

Download PDF Visit The Full Archive

Related Articles

DCPC Board Approves New Intramural Laboratory for Diet And Nutrition; NCAB to Consider It Next

May 22, 1987

Phase III Five-Year Data Show Erbitux Increases Survival Of Head And Neck Cancer

September 26, 2008

Multivitamin Use Doesn’t Impact Outcomes, Study Finds

September 24, 2010

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

January 25, 2013

NCI Selects 15 Awardees to Operate the Cancer Information Service.

January 7, 2005

In Brief: $100 Million Being Spent On Interferon In U.S., Rauscher Says; DeVita; Criticism Deserved

April 4, 1980